
David A. Alagpulinsa, PhD
@alagsdave
Assistant Professor @Yale @YaleMed⏐Hematopoiesis⏐Type 1 diabetes⏐CVD⏐Statistical Genetics⏐Hematologic disease⏐Low key is the best key⏐Writing⏐Nature⏐
ID: 1000366034
https://medicine.yale.edu/lab/alagpulinsa/ 09-12-2012 22:42:44
1,1K Tweet
365 Followers
310 Following





Final call! Submit your abstract today to be considered for a poster or short talk at Cell Symposia #CSPrecisionGen25 — don’t miss this opportunity to showcase your research! hubs.li/Q03pVtqW0






📘 Our #Neuroimmunology and #Neurodegeneration collection covers a broad range of topics including macular degeneration, the role of #microglia, β-amyloid transport, CNS #autoimmunity, and the sympathetic control of cancer progression: hubs.la/Q03qT7RW0 Keystone Symposia


Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma Nature Medicine nature.com/articles/s4159…


A study harnessed machine learning/generative artificial intelligence approaches, identifying and validating a miRNA-based DRS for #T1D discrimination and treatment efficacy prediction. Nature Medicine nature.com/articles/s4159…

Human islet proteome changes in stage 1 type 1 diabetes reveals increased inflammation and decreased endoplasmic reticulum stress. @Qian_weijun, UF Diabetes Institute, Omics PNNL link.springer.com/article/10.100… 🔓



PanKbase #ADA2025 spotlight: PI Anna Gloyn presents Sun. the 22nd at 2pm CDT. Session: Genetic Regulation of Beta-Cell Mass and Function in Humans: Lessons from GWAS and Rare Genetics. Her talk: "Integrating Multiomic Data to Understand Complex Gene Regulatory Networks in Islets"





